Impact of Catheter Stabilization on Catheter Micro-Motion and Function in a Healthy Population.

Griffith University0 个研究点目标入组 40 人开始时间: 2023年3月28日最近更新: 2023年4月3日

适应症

试验速览

暂无简介。

•Female or Male sex
•18-65 years of age
•Not pregnant at time of recruitment and within 48 hrs of Day 1 procedures (self-reported)
•Normal haemotology results as per reference range determined by our laboratory.
•Normal coagulation results as per reference range determined by our laboratory.
•Target cephalic veins readily cannulatable (i.e., equal to approximately 2 mm)
•Able and willing to provide verbal and written consent
•Must be an Australian citizen with current Medicare card

•History of pro coagulative state / condition (e.g., previous deep vein thrombosis)
•Currently on any anti-coagulant or platelet inhibitor medication. Use of NSAIDs and aspirin will be documented however are not exclusionary.
•Haemophilia or any current or history of bleeding disorder or tendency
•Presence or report of current blood borne disease/infection (e.g., hepatitis, HIV, leukemia, lymphoma)
•Difficult vascular access (i.e., vein must be readily palpable and cannulatable – no less than approximately 2 mm diameter
•Allergy or sensitivity to chlorhexidine gluconate, isopropyl alcohol, latex, or skin adhesives
•BMI less than 18.5 kg/m^2 or greater than 35 kg/m^2
•Positive results for the urine drug screen at screening or check-in (including opiates, methadone, cocaine, amphetamines)
•History or presence of alcoholism (self-reported) or drug abuse within the past 2 years
•A current or previous medical, physical, mental / cognitive disorder or anatomical conditions that, in the opinion of the chief or sub-investigator, would place the patient at risk, would make them unable to perform study procedures or has the potential to confound interpretation of the study results. (e.g., musculo-skeletal injury, chronic back pain)
•Employed by Becton Dickinson, Teleflex Medical, ICUMedical or BBraun (conflict of interest)

发起方